ArticleTherapeutic advances in medical oncology2025

S-1 plus oxaliplatin versus modified FOLFIRINOX for advanced pancreatic adenocarcinoma after gemcitabine plus nab-paclitaxel failure.

Hui Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.